← Back
Amicus Therapeutics
FOLD
No insider bought Amicus Therapeutics stock in the last year. They sold it 12 times, $5.09 million in all.
No price data yet — the yfinance scanner hasn't produced bars for FOLD.
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, four insiders sold Amicus Therapeutics stock and none bought. None of the 12 sales is marked on its filing as planned in advance; all by company executives. The biggest seller was Bradley L. Campbell, President and CEO.
All reports
Every insider trade and SEC report we hold for Amicus Therapeutics.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Dec 23, 2025SoldDavid Michael ClarkDec 23, 2025 · Traded Dec 19, 2025 · Chief People Officer25,642 @ $14.17$363.4K
Dec 17, 2025SoldBradley L. CampbellDec 17, 2025 · Traded Dec 15, 2025 · President and CEO77,926 @ $10.86$846K
Dec 17, 2025SoldDavid Michael ClarkDec 17, 2025 · Traded Dec 15, 2025 · Chief People Officer25,643 @ $11.00$282.1K
Dec 3, 2025SoldBradley L. CampbellDec 3, 2025 · Traded Dec 1, 2025 · President and CEO14,587 @ $10.01$146K
7 more with Pro →